NCT03429816 2025-03-27
OPPOSITE
University Hospital Heidelberg
Phase NA Completed
Clinical Trials
6 trialsNCT06418516 2024-05-17
ANGELA
Centre of Postgraduate Medical Education
Phase NA Not yet recruiting
NCT05619016 2022-11-30
[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors
Karolinska University Hospital
Phase 2 Unknown
NCT00397904 2015-11-25
Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00470184 2013-11-25
Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer
Roswell Park Cancer Institute
Phase 2 Completed
NCT00566800 2013-09-17
Erlotinib in Treating Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 1 Unknown